Home › Funds › Ally Bridge Group (NY) LLC › PALI
Ally Bridge Group (NY) LLC position in PALI
PALISADE BIO INC · Health Care
Ally Bridge Group (NY) LLC reported holding 1,229,000 shares of PALI (PALISADE BIO INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 2.27% of its reported portfolio and ranking #14 among its reported holdings. Ally Bridge Group (NY) LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's PALI position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in PALI in Q2 2026 at 1,229,000 shares (US$2.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.23M | $2.57M | New |
About PALI and 13F data
PALI (PALISADE BIO INC) is a Health Care company. 113 other funds we track also report a position in PALI — the largest reported positions include Soleus Capital Management, L.P. (US$27.3M), B Group, Inc. (US$23.9M), Octagon Capital Advisors LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PALI
- Soleus Capital Management, L.P. 13.06M sh · $27.30M · Q2 2026
- B Group, Inc. 11.41M sh · $23.86M · Q2 2026
- Octagon Capital Advisors LP 10.28M sh · $21.48M · Q2 2026
- Boxer Capital Management, LLC 4.80M sh · $10.03M · Q2 2026
- Squadron Capital Management LLC 3.00M sh · $6.27M · Q2 2026
- Propel Bio Management, LLC 2.58M sh · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.28M sh · $4.78M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 2.26M sh · $4.72M · Q2 2026
- HighVista Strategies LLC 2.03M sh · $4.24M · Q2 2026
- Artia Global Partners LP 1.99M sh · $4.16M · Q2 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 1.73M sh · $3.62M · Q2 2026
- Creek Drive Management Group LLC 440.00K sh · $919.60K · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held PALI?
Ally Bridge Group (NY) LLC has disclosed PALI holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Ally Bridge Group (NY) LLC's current position in PALI?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 1.23M shares of PALI (PALISADE BIO INC), valued at $2.57M, representing 2.27% of its reported portfolio and ranking #14.
Has Ally Bridge Group (NY) LLC been buying or selling PALI?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC newly opened its position in PALI.
Which other funds hold PALI?
Other major institutional holders of PALI include Soleus Capital Management, L.P., B Group, Inc., Octagon Capital Advisors LP, among 113 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.